1 year return (CAGR)
976.25%
GT Biopharma Inc Exchange (NASDAQ, USD)
GTBP
8.61
+2.43 (+39.32%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-1.47%
5 year return (CAGR)
-49.54%
10 year return (CAGR)
-55.85%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
388.39M
Price/Sales
-
Ent value
385.65M
Price/Book
108.82
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-1.59%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-0.64%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 6.59 |
| Daily high | 8.82 |
| Daily low | 6.59 |
| Daily Volume | 533K |
| All-time high | 1530000000.00 |
| 1y analyst estimate | 3.00 |
| Beta | 0.91 |
| EPS (TTM) | -0.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GTBP | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.75% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 11 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -89.39% | -10.68% |
| Avg time to new high | 343 days | 12 days |
| Max time to new high | 8065 days | 1805 days |
News
